BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1312080)

  • 1. Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas.
    Ito M; Yasui W; Nakayama H; Yokozaki H; Ito H; Tahara E
    Jpn J Cancer Res; 1992 Jan; 83(1):86-92. PubMed ID: 1312080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
    Ito M; Yasui W; Kyo E; Yokozaki H; Nakayama H; Ito H; Tahara E
    Cancer Res; 1992 Jan; 52(2):295-300. PubMed ID: 1309437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
    Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
    Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a transforming growth factor beta-1 activator derived from a human gastric cancer cell line.
    Horimoto M; Kato J; Takimoto R; Terui T; Mogi Y; Niitsu Y
    Br J Cancer; 1995 Sep; 72(3):676-82. PubMed ID: 7669580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas.
    Yoshida K; Yokozaki H; Niimoto M; Ito H; Ito M; Tahara E
    Int J Cancer; 1989 Sep; 44(3):394-8. PubMed ID: 2777404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
    Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma.
    Naef M; Ishiwata T; Friess H; Büchler MW; Gold LI; Korc M
    Int J Cancer; 1997 Apr; 71(2):131-7. PubMed ID: 9139831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms.
    Henriksen R; Gobl A; Wilander E; Oberg K; Miyazono K; Funa K
    Lab Invest; 1995 Aug; 73(2):213-20. PubMed ID: 7637321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.
    Mizoi T; Ohtani H; Miyazono K; Miyazawa M; Matsuno S; Nagura H
    Cancer Res; 1993 Jan; 53(1):183-90. PubMed ID: 8416744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical identification of transforming growth factor-beta and its binding protein in human gastrointestinal carcinoma.
    Mizoi T; Ohtani H; Matsuno S; Nagura H
    Tohoku J Exp Med; 1992 Oct; 168(2):271-3. PubMed ID: 1339102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
    Piek E; Franzén P; Heldin CH; ten Dijke P
    J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
    Koli K; Keski-Oja J
    Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of transforming growth factor-beta and its receptors in gastric carcinoma tissue.
    Kai T; Taketazu F; Kawakami M; Shimanuki K; Yamada S; Miyazono K; Kato M; Miyata M
    Jpn J Cancer Res; 1996 Mar; 87(3):296-304. PubMed ID: 8613433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
    Kang SH; Bang YJ; Im YH; Yang HK; Lee DA; Lee HY; Lee HS; Kim NK; Kim SJ
    Oncogene; 1999 Dec; 18(51):7280-6. PubMed ID: 10602482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TGF-beta 1 and TGF-beta type II receptor in gastric cancer.
    Park D; Son HJ; Song SY; Choe WH; Lim YJ; Park SJ; Kim JJ; Kim YH; Rhee PL; Paik SW; Rhee JC; Choi KW
    Korean J Intern Med; 2002 Sep; 17(3):160-6. PubMed ID: 12353499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of TGF-beta and its receptors in the kidney.
    Ando T; Okuda S; Yanagida T; Fujishima M
    Miner Electrolyte Metab; 1998; 24(2-3):149-53. PubMed ID: 9525698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.